Skip to main content

Table 2 Study of factors associated with recurrence. Bi-variable analyses between host factors, primary cyst and treatment used with recurrence

From: Recurrence of cystic echinococcosis in an endemic area: a retrospective study

Patients with recurrences

n/N (%)

OR (IC95%)

p-value*

Host factors

 Age ≤ 59 years

17/124 (13.7)

1.6 (0.6–4.0)

0.244

 Male sex

18/133 (13.5)

1.7 (0.6–4.3)

0.243

 Patients from rural areas

17/148 (11.5)

0.9 (0.4–2.4)

0.982

 Professional activity-agriculture/livestock

2/31 (6.5)

0.4 (0.1–2.1)

0.340

 Contact with animals

4/60 (6.7)

0.4 (0.1–1.4)

0.166

 Immigrants

0/6 (0.0)

 Comorbidity

7/73 (9.6)

0.7 (0.2–1.8-)

0.526

Cyst primary factors

 Complicated

9/88 (10.2)

0.8 (0.3–1.9)

0.622

 Cyst size (≥7 cm)

16/122 (13.1)

1.4 (0.6–3.4)

0.405

Cyst location

 Liver

 Lung

 Others/disseminated

19/193 (9.8)

0/12 (0.0)

7/31 (22.6)

0.3 (0.1–0.9)

2.7 (1.1–7.1)

0.028*

0.037*

No. of cysts (≥2)

11/80 (13.8)

1.4 (0.6–3.2)

0.432

WHO classification

 CE1

 CE2

 CE3

 CE4

 CE5

19/193 (9.8)

0/10 (0.0)

8/59 (13.6)

4/32 (12.5)

2/30 (6.7)

5/62 (8.1)

 

0.587

Factors associated to treatment

 Combinated treatment (Antihelminths & surgical)

20/141 (14.2)

2.3 (1.4–6.5)

0.094

 Surgical technics

5/76 (6.6)

 Surgical treatment complications

7/38 (18.4)

2.0 (0.7–5.2)

0.142

  1. *p-value of the test: Total patients with treatment with curative intention-follow-up & Recurrences. Statistical significance level of 5% (p < 0.05)